Follow
Dayson Friaça Moreira
Dayson Friaça Moreira
Appia Bio
Verified email at coh.org
Title
Cited by
Cited by
Year
TLR9-targeted STAT3 silencing abrogates immunosuppressive activity of myeloid-derived suppressor cells from prostate cancer patients
DMS Hossain, SK Pal, D Moreira, P Duttagupta, Q Zhang, H Won, J Jones, ...
Clinical Cancer Research 21 (16), 3771-3782, 2015
2002015
Cell death‐associated molecular‐pattern molecules: inflammatory signaling and control
B Sangiuliano, NM Pérez, DF Moreira, JE Belizário
Mediators of inflammation 2014 (1), 821043, 2014
1632014
Myeloid cell–targeted miR-146a mimic inhibits NF-κB–driven inflammation and leukemia progression in vivo
YL Su, X Wang, M Mann, TP Adamus, D Wang, DF Moreira, Z Zhang, ...
Blood, The Journal of the American Society of Hematology 135 (3), 167-180, 2020
1232020
Leukemia cell–targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity
DMS Hossain, C Dos Santos, Q Zhang, A Kozlowska, H Liu, C Gao, ...
Blood, The Journal of the American Society of Hematology 123 (1), 15-25, 2014
1152014
Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia.
KM Zhang Q, Hossain DM, Duttagupta P, Moreira D, Zhao X, Won H, Buettner R ...
Blood 127 (13), 1687-700, 2016
100*2016
The esc-eorp euro-endo (european infective endocarditis) registry
G Habib, P Lancellotti, PA Erba, A Sadeghpour, M Meshaal, A Sambola, ...
European Heart Journal-Quality of Care and Clinical Outcomes 5 (3), 202-207, 2019
872019
STAT3 inhibition combined with CpG immunostimulation activates antitumor immunity to eradicate genetically distinct castration-resistant prostate cancers
D Moreira, T Adamus, X Zhao, YL Su, Z Zhang, SV White, P Swiderski, ...
Clinical Cancer Research 24 (23), 5948-5962, 2018
872018
Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry
G Boriani, M Proietti, C Laroche, L Fauchier, F Marin, M Nabauer, ...
EP Europace 21 (7), 1013-1022, 2019
742019
Intracellular processing of immunostimulatory CpG–siRNA: Toll-like receptor 9 facilitates siRNA dicing and endosomal escape
S Nechaev, C Gao, D Moreira, P Swiderski, A Jozwiak, CM Kowolik, ...
Journal of Controlled Release 170 (3), 307-315, 2013
682013
Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity
D Moreira, S Sampath, H Won, SV White, YL Su, M Alcantara, C Wang, ...
The Journal of clinical investigation 131 (2), 2021
662021
TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells
D Moreira, Q Zhang, DMS Hossain, S Nechaev, H Li, CM Kowolik, ...
Oncotarget 6 (19), 17302, 2015
662015
Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities
M Kortylewski, D Moreira
Cancer Immunology, Immunotherapy 66, 979-988, 2017
592017
TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs.
KM Won H, Moreira D, Gao C, Duttagupta P, Zhao X, Manuel E, Diamond D, Yuan ...
J Leukocyte Biology, 2017
562017
Reduced T-cell numbers and elevated levels of immunomodulatory cytokines in metastatic prostate cancer patients de novo resistant to abiraterone and/or enzalutamide therapy
SK Pal, D Moreira, H Won, SW White, P Duttagupta, M Lucia, J Jones, ...
International Journal of Molecular Sciences 20 (8), 1831, 2019
542019
Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs
KPC Araujo, G Bonuccelli, CN Duarte, TP Gaiad, DF Moreira, D Feder, ...
PLoS One 8 (4), e61367, 2013
532013
Using pharmacogenomic databases for discovering patient-target genes and small molecule candidates to cancer therapy
JE Belizário, BA Sangiuliano, M Perez-Sosa, JM Neyra, DF Moreira
Frontiers in pharmacology 7, 312, 2016
372016
Role of SOCS-1 gene on melanoma cell growth and tumor development
JAB Scutti, AL Matsuo, FV Pereira, MH Massaoka, CR Figueiredo, ...
Translational oncology 4 (2), 101-109, 2011
362011
B cell lymphoma immunotherapy using TLR9-targeted oligonucleotide STAT3 inhibitors
X Zhao, Z Zhang, D Moreira, YL Su, H Won, T Adamus, Z Dong, Y Liang, ...
Molecular Therapy 26 (3), 695-707, 2018
352018
Differential antitumor effects of IgG and IgM monoclonal antibodies and their synthetic complementarity-determining regions directed to new targets of B16F10-Nex2 melanoma cells
AS Dobroff, EG Rodrigues, MA Juliano, DM Friaça, ES Nakayasu, ...
Translational Oncology 3 (4), 204-217, 2010
352010
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling
BMC Cancer 15 (70), 2015
342015
The system can't perform the operation now. Try again later.
Articles 1–20